Our history
2005 – Beginning of TMS Use in Rennes
In 2005, doctors in the Department of Psychiatry at the University of Rennes began using Transcranial Magnetic Stimulation (TMS) to treat depression.
Very quickly, they realized the need for a reliable and precise localization system.
They also wanted equipment that was simple to use, to make TMS reproducible.
Collaboration with the VISAGES Research Team
Thus, a collaboration started with the VISAGES research team at INRIA / INSERM.
This team was already experienced in image-guided neurosurgery.
Their goal was to develop an innovative tool.
Creation of the SYNEIKA ONE Neuronavigator
This collaboration resulted in a unique neuronavigator designed for TMS.
It is derived from neurosurgery tools and meant for routine therapeutic use.
Named SYNEIKA ONE, it offers an accelerated learning curve and maintains high productivity.
2009 – Foundation and Patent
Winner of the i-LAB competition in 2008 and 2011, supported by BPI France and the Brittany Region, SYNEIKA was founded in 2009.
The same year, the process for automatic localisation of anatomical targets on individual MRI scans was patented.
2010 – Certification and Market Launch
Syneika's Quality Management System became ISO 13485 certified.
Additionally, the Syneika One neuronavigator received CE marking as a class IIb medical device and was commercialized.
2011 – New Hospital Clients
The Centre Hospitalier le Vinatier (69) and the CESAME (49) started using Syneika systems.
2012 – Partnership with Mag&More
Syneika partnered with Mag&More to offer a complete solution for neuronavigated Transcranial Magnetic Stimulation.
This enables precise treatments that respect both operators and patients.
2013 – First Stimulator and Axilum Robotics Collaboration
The first PowerMAG transcranial magnetic stimulator was delivered to Lille University Hospital.
In the same year, Syneika began collaborating with Axilum Robotics.
A TMS-Robot was piloted for the first time by a Syneika One neuronavigator (version 2) at Ambroise Paré Hospital, for clinical research on neuropathic pain within the INSERM U987 unit.
2014 – Chronic Pain Treatment and Remote Maintenance
Following Ambroise Paré, Syneika equipped its first clients to treat chronic pain with TMS.
Moreover, remote maintenance of the equipment was implemented through a secure connection certified by ANSSI.
2015 – First International Success and New Clients
Syneika achieved its first international success in Indonesia with a Syneika One neuronavigator combined with an Axilum-Robotics TMS-Robot.
That year, Syneika also equipped the Department of Adult Psychiatry at University Hospitals Pitié Salpêtrière.
2016 – Version 2.1 with Improvements
Version 2.1 of Syneika One was released, featuring connection to PACS and improved guidance accuracy.
2018 – International Expansion
Syneika One neuronavigators and Axilum-Robotics TMS-Robots were deployed in Bruges, Belgium, and at the Les Flamboyants Clinic on Reunion Island.
2019 – Collaboration with MediCIS
Syneika partnered with the MediCIS research team (INSERM/LTSI/University of Rennes 1) to optimise automatic identification of anatomical targets on MRI scans.
2020 – New Somatotopic Identification Feature
Syneika One introduced automatic identification of somatotopic representations of the face and lower limb in the primary motor cortex.
This helps caregivers better personalise chronic pain treatments.
2022 – Eighth Neuronavigator and Results
An eighth Syneika One neuronavigator was installed in Indonesia.
Since launch, the device has enabled precise treatment of 10,000 patients during 150,000 neuronavigated TMS sessions.
